PTCHFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as PRTCY
PureTech Health plc
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 29, 2026
$1.48+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 7.0
- Dividend yield
- –
PureTech Health statistics
Financials through Dec 31, 2024, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | PureTech Health | Industry median |
|---|---|---|
| Market Cap | $357.69M | $197.05M |
| Enterprise Value | $70.28M | $106.56M |
| PE Ratio | 7.05 | 20.52 |
| PS Ratio | 74.09 | 3.93 |
| PB Ratio | 0.86 | 2.14 |
| P/TBV Ratio | 0.86 | 2.46 |
Enterprise value
| Measure | PureTech Health | Industry median |
|---|---|---|
| EV / Sales | 14.56 | 2.69 |
Income (trailing twelve months)
| Measure | PureTech Health | Industry median |
|---|---|---|
| Revenue | $4.83M | $57.94M |
| Operating Income | -$136.10M | -$21.44M |
| Pretax Income | $23.77M | -$14.45M |
| Net Income | $53.51M | -$22.46M |
| EBITDA | -$132.52M | -$16.91M |
| EPS (Diluted) | $0.21 | -$0.83 |
Margins
| Measure | PureTech Health | Industry median |
|---|---|---|
| Operating Margin | -2818.9% | -44.5% |
| Pretax Margin | 492.4% | -13.0% |
| Profit Margin | 1108.3% | -39.2% |
| EBITDA Margin | -2744.9% | -31.3% |
| FCF Margin | -2783.3% | -8.85% |
Returns
| Measure | PureTech Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | 12.9% | -53.1% |
| Return on Assets (ROA) | 8.88% | -41.0% |
| Return on Invested Capital (ROIC) | -101.5% | -32.0% |
| Return on Capital Employed (ROCE) | -24.2% | -37.8% |
Growth
| Measure | PureTech Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 45.0% | 6.01% |
| Revenue Growth (3Y CAGR) | -34.8% | 2.25% |
| Revenue Growth (5Y CAGR) | -13.2% | 6.42% |
| EPS Growth (5Y CAGR) | -32.0% | 3.77% |
Balance sheet
| Measure | PureTech Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $280.64M | $62.42M |
| Net Cash (Debt) | $280.64M | $15.68M |
| Net Cash Per Share | $1.16 | $0.65 |
| Equity (Book Value) | $414.71M | $48.79M |
| Book Value Per Share | $1.72 | $1.36 |
| Tangible Book Value | $414.71M | $23.06M |
| Working Capital | $344.87M | $75.77M |
Financial position
| Measure | PureTech Health | Industry median |
|---|---|---|
| Current Ratio | 9.33 | 3.30 |
| Quick Ratio | 6.82 | 2.39 |
| Interest Coverage | -78.62 | -7.12 |
Cash flow (trailing twelve months)
| Measure | PureTech Health | Industry median |
|---|---|---|
| Operating Cash Flow | -$134.37M | -$12.35M |
| Capital Expenditures | -$11.00K | -$1.06M |
| Free Cash Flow | -$134.38M | -$20.28M |
| FCF Per Share | -$0.56 | -$0.41 |
Efficiency
| Measure | PureTech Health | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.38 |
Dividends and yields
| Measure | PureTech Health | Industry median |
|---|---|---|
| Earnings Yield | 15.0% | -21.2% |
| FCF Yield | -37.6% | -7.64% |
Shares
| Measure | PureTech Health | Industry median |
|---|---|---|
| Shares Outstanding | 241,684,000 | 59,128,900 |
| Shares Change (YoY) | -7.34% | 11.1% |
| Float | 241,684,000 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
| Shares Held by Institutions | 0.00% | 59.4% |
Taxes
| Measure | PureTech Health | Industry median |
|---|---|---|
| Income Tax | -$4.01M | $91.50K |
| Effective Tax Rate | -16.9% | 20.6% |
Scores
| Measure | PureTech Health | Industry median |
|---|---|---|
| Graham Number | $2.85 | $17.36 |
| Graham Upside | 92.4% | -45.5% |
| Altman Z-Score | 1.13 | 0.10 |
| Piotroski F-Score | 6 | 4 |
Calculated by StockData from PureTech Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.